| __timestamp | Genmab A/S | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 850385000 | 2614539000 |
| Thursday, January 1, 2015 | 1133041000 | 3711019000 |
| Friday, January 1, 2016 | 1816122000 | 4560733000 |
| Sunday, January 1, 2017 | 2365436000 | 5475166000 |
| Monday, January 1, 2018 | 3025137000 | 6276700000 |
| Tuesday, January 1, 2019 | 5366000000 | 7081200000 |
| Wednesday, January 1, 2020 | 10111000000 | 7377200000 |
| Friday, January 1, 2021 | 8482000000 | 13634200000 |
| Saturday, January 1, 2022 | 14595000000 | 10612500000 |
| Sunday, January 1, 2023 | 16248000000 | 11301400000 |
| Monday, January 1, 2024 | 12231500000 |
In pursuit of knowledge
In the competitive landscape of biotechnology, Regeneron Pharmaceuticals, Inc. and Genmab A/S have emerged as key players. Over the past decade, both companies have demonstrated impressive growth in gross profit, reflecting their strategic advancements and market adaptability.
From 2014 to 2023, Genmab A/S saw its gross profit surge by nearly 1,810%, starting from a modest 850 million to an impressive 16.25 billion. Meanwhile, Regeneron Pharmaceuticals, Inc. experienced a robust growth of approximately 332%, with profits climbing from 2.61 billion to 11.3 billion.
The year 2021 marked a pivotal point for Regeneron, achieving its highest gross profit of 13.63 billion, while Genmab continued its upward trajectory, peaking in 2023. This data underscores the dynamic nature of the biotech industry and the relentless pursuit of innovation by these two giants.
Who Generates Higher Gross Profit? Johnson & Johnson or Genmab A/S
Vertex Pharmaceuticals Incorporated vs Regeneron Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Annual Revenue Comparison: Regeneron Pharmaceuticals, Inc. vs Genmab A/S
Research and Development Investment: Regeneron Pharmaceuticals, Inc. vs Genmab A/S
Key Insights on Gross Profit: Regeneron Pharmaceuticals, Inc. vs Incyte Corporation
Regeneron Pharmaceuticals, Inc. and Jazz Pharmaceuticals plc: A Detailed Gross Profit Analysis
Regeneron Pharmaceuticals, Inc. vs Amneal Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Regeneron Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.
Genmab A/S and BioMarin Pharmaceutical Inc.: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing Genmab A/S and Ascendis Pharma A/S
Who Generates Higher Gross Profit? Genmab A/S or Vericel Corporation
Genmab A/S and HUTCHMED (China) Limited: A Detailed Gross Profit Analysis